3-Methyl-7-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)-2-((6-methylpyridin-2-yl)methyl)-3,4-dihydropyrrolo[1,2-a]pyrazin-1(2H)-one

ID: ALA4083098

PubChem CID: 137647232

Max Phase: Preclinical

Molecular Formula: C23H24N8O

Molecular Weight: 428.50

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cccc(CN2C(=O)c3cc(-c4ccnc(Nc5ccnn5C)n4)cn3CC2C)n1

Standard InChI:  InChI=1S/C23H24N8O/c1-15-5-4-6-18(26-15)14-31-16(2)12-30-13-17(11-20(30)22(31)32)19-7-9-24-23(27-19)28-21-8-10-25-29(21)3/h4-11,13,16H,12,14H2,1-3H3,(H,24,27,28)

Standard InChI Key:  NKHSCFWQFSFQBX-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 32 36  0  0  0  0  0  0  0  0999 V2000
   15.7109  -10.3634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7098  -11.1871    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4220  -11.5961    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.1358  -11.1866    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1329  -10.3598    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.4202   -9.9504    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4177   -9.1291    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8482  -11.5941    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.5553  -11.1844    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0757   -8.6418    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7453   -8.6457    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9954   -7.8678    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8135   -7.8679    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.2225   -7.1628    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8138   -6.4530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9956   -6.4529    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.5862   -7.1625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7649   -7.1634    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.5870   -5.7452    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9956   -5.0374    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8116   -5.0427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2201   -4.3358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8114   -3.6271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9900   -3.6298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5852   -4.3373    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.5789   -2.9236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3006  -11.5103    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.8464  -10.9022    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.4367  -10.1950    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6377  -10.3663    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4737  -12.3089    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2229   -5.7456    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  6  7  1  0
  4  8  1  0
  8  9  1  0
  7 10  2  0
 10 13  1  0
 12 11  2  0
 11  7  1  0
 12 13  1  0
 12 17  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 16 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 24 26  1  0
  9 27  1  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30  9  2  0
 27 31  1  0
 15 32  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4083098

    ---

Associated Targets(Human)

MAP2K1 Tclin Dual specificity mitogen-activated protein kinase kinase 1 (4127 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK1 Tchem MAP kinase ERK2 (25055 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver (3974 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 428.50Molecular Weight (Monoisotopic): 428.2073AlogP: 3.17#Rotatable Bonds: 5
Polar Surface Area: 93.76Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 12.19CX Basic pKa: 4.85CX LogP: 2.20CX LogD: 2.20
Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.52Np Likeness Score: -1.52

References

1. Ward RA, Bethel P, Cook C, Davies E, Debreczeni JE, Fairley G, Feron L, Flemington V, Graham MA, Greenwood R, Griffin N, Hanson L, Hopcroft P, Howard TD, Hudson J, James M, Jones CD, Jones CR, Lamont S, Lewis R, Lindsay N, Roberts K, Simpson I, St-Gallay S, Swallow S, Tang J, Tonge M, Wang Z, Zhai B..  (2017)  Structure-Guided Discovery of Potent and Selective Inhibitors of ERK1/2 from a Modestly Active and Promiscuous Chemical Start Point.,  60  (8): [PMID:28376306] [10.1021/acs.jmedchem.7b00267]
2. Ward RA, Bethel P, Cook C, Davies E, Debreczeni JE, Fairley G, Feron L, Flemington V, Graham MA, Greenwood R, Griffin N, Hanson L, Hopcroft P, Howard TD, Hudson J, James M, Jones CD, Jones CR, Lamont S, Lewis R, Lindsay N, Roberts K, Simpson I, St-Gallay S, Swallow S, Tang J, Tonge M, Wang Z, Zhai B..  (2017)  Structure-Guided Discovery of Potent and Selective Inhibitors of ERK1/2 from a Modestly Active and Promiscuous Chemical Start Point.,  60  (8): [PMID:28376306] [10.1021/acs.jmedchem.7b00267]

Source